Helsinn Chemical Operations, Biasca, Switzerland and the pharmaceutical technologies and services division of Cardinal Health Inc. announced a cooperative alliance.
The venture is in the area of comprehensive drug substance/drug product research, development and manufacturing. The alliance combines Cardinal Health’s capabilities in chemical synthesis route-finding and drug development with Helsinn’s scale-up and manufacturing skills for delivering high quality APIs, Helsinn company executives said.
The effort will serve the needs of pharmaceutical and biotechnology companies that lack sufficient re-sources or expertise in advanced drug development and manufacturing.
Helsinn Chemical and Cardinal Health Form Alliance
Published November 11, 2005
blog comments powered by Disqus